Humana is backpedaling after sending an erroneous letter to about 12,000 plan holders that said it would no longer be paying for a generic Flonase because it was never approved by the FDA. Except it was.
The Austin American Statesman has a quick story about the error, which was caught by resident David Crump, “an insurance agent with a knack for record-keeping and filing official complaints,” as the newspaper describes him. The letter told the plan holders that they would have to pay full price for the generic fluticasone propionate nasal spray. Crump said it didn’t pass his smell test—and sure enough, the Food and Drug Administration approved the medication back in 2006. So off he went, filing a complaint with the Texas Department of Insurance.
Humana told the newspaper that the mistake affected less than 1 percent of its nearly 2 million Texas membership base. A spokeswoman said the company would be mailing new letters to clarify that the drug is still part of the plans.